Bank of New York Mellon Corp - ADURO BIOTECH INC ownership

ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 95 filers reported holding ADURO BIOTECH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ADURO BIOTECH INC
ValueSharesWeighting
Q3 2020$738,000
+6.8%
303,590
+1.4%
0.00%
Q2 2020$691,000
-15.1%
299,352
+0.8%
0.00%
Q1 2020$814,000
+169.5%
296,881
+16.0%
0.00%
Q4 2019$302,000
+26.4%
255,864
+13.5%
0.00%
Q3 2019$239,000
-33.6%
225,368
-3.4%
0.00%
Q2 2019$360,000
-66.2%
233,369
-12.9%
0.00%
Q1 2019$1,066,000
+53.4%
267,882
+1.8%
0.00%
Q4 2018$695,000
-57.8%
263,127
+17.6%
0.00%
Q3 2018$1,645,000
+6.7%
223,784
+1.6%
0.00%
Q2 2018$1,541,000
-9.8%
220,247
+19.8%
0.00%
Q1 2018$1,709,000
+34.1%
183,860
+8.2%
0.00%
Q4 2017$1,274,000
-31.9%
169,868
-3.3%
0.00%
-100.0%
Q3 2017$1,871,000
+15.8%
175,642
+23.9%
0.00%
Q2 2017$1,616,000
+1.4%
141,799
-4.3%
0.00%
Q1 2017$1,593,000
-2.1%
148,166
+3.8%
0.00%
Q4 2016$1,627,000
+7.6%
142,696
+17.4%
0.00%
Q3 2016$1,512,000
+31.2%
121,581
+19.4%
0.00%
Q2 2016$1,152,000
+59.3%
101,858
+80.7%
0.00%
Q1 2016$723,000
-40.8%
56,376
+29.8%
0.00%
Q4 2015$1,222,000
+177.7%
43,436
+91.2%
0.00%
Q3 2015$440,000
-50.2%
22,720
-22.0%
0.00%
Q2 2015$883,00029,1280.00%
Other shareholders
ADURO BIOTECH INC shareholders Q2 2019
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 2,106,734$40,807,00012.39%
Rock Springs Capital Management LP 415,000$8,039,0000.65%
CLOUGH CAPITAL PARTNERS L P 592,697$11,481,0000.50%
NJ State Employees Deferred Compensation Plan 53,300$1,032,0000.22%
Orbimed Advisors 1,065,522$20,639,0000.21%
Point72 Asset Management, L.P. 845,700$16,381,0000.13%
LMCG INVESTMENTS, LLC 244,382$4,734,0000.10%
EverPoint Asset Management, LLC 150,000$2,906,0000.08%
M&T BANK CORP 566,560$10,974,0000.08%
GLOBEFLEX CAPITAL L P 15,200$294,0000.06%
View complete list of ADURO BIOTECH INC shareholders